chrisvoncsefalvay/vaers-outcomes huggingface dataset:
headache for two moths after getting their Moderna covid19 vaccine; swollen lymph nodes; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache for two moths after getting their Moderna covid19 vaccine) and LYMPHADENOPATHY (swollen lymph nodes) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Immunocompromised and Asthma.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (headache for two moths after getting their Moderna covid19 vaccine) and LYMPHADENOPATHY (swollen lymph nodes). At the time of the report, HEADACHE (headache for two moths after getting their Moderna covid19 vaccine) and LYMPHADENOPATHY (swollen lymph nodes) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. No treatment medications were provided.   This case was linked to MOD-2021-330514, MOD-2021-330698 (Patient Link).
Fever up to 104, pneumonia diagnosis, very high blood pressure over 200. Hospitalized on antibiotics for 24 hours.
lymph nodes swelling and inflammation (under arm, around collarbones) on the side of the vaccination (left)
Chills, fatigue appeared few days after vaccination, but then disappeared after day 5. However stomach pain appeared and persist past one week after vaccination. Cannot tell if this is from vaccine or not, but reporting about it anyway.
Computers were down a ProQuad  MMRV was pulled and given instead of a regular MMR  The mistake was noted when putting lot number information from paper chart into computer
Information has been received from a physician concerning a 16 year old female patient who on 10-MAY-2008 was vaccinated with the first dose of GARDASIL vaccine (yeast). On 10-MAY-2008 the patient had an injection site reaction (local reaction with erythema) for a few days. Subsequently, the patient recovered from local reaction with erythema for a few days. Additional information has been requested.
Boostrix and the syringe leaked administrating less than the recommended volume; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete dose administered in a 55-year-old male patient who received DTPa (Reduced antigen) (Boostrix) (batch number 34FR4, expiry date 23-SEP-2024) for prophylaxis.  On 10-MAY-2023, the patient received Boostrix. On 10-MAY-2023, an unknown time after receiving Boostrix, the patient experienced incomplete dose administered (Verbatim: Boostrix and the syringe leaked administrating less than the recommended volume). The outcome of the incomplete dose administered was unknown.  This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional Information: GSK Receipt Date: 10-MAY-2023 The reporter had stated that, Boostrix product leaked and does not touched the patient's arm..  The plunger disconnected from the rest of the injection and it leaked directly to the floor. Pharmacist reported on 10 May 2023 that patient received today (at the day of reporting) Boostrix and the syringe had leaked, administrating less than the recommended volume.  The vaccine administration facility was the same as primary reporter. The reporter had denied consent to follow-up. The injection had leaked directly to the floor and the patient had received less than the recommended volume, which had led to Incomplete dose administered.
The day of the vaccine almost immediately after there was bad pain at the injection site, and the site is painful and bruised, itchy, and feels like a knot is under my skin.  The day after receiving the second shot, around 12:30pm, I became very drowsy, dizzy, and developed a migraine. I left work around 3:00pm, and came home. By this time I was also experiencing head spasms when I moved. I layed in bed from 3:30-10:30 am the next day trying to sleep off the symptoms, also I couldn?t move without the head spasms and dizziness starting, and the migraine was too bad to want to get up. The next day the migraine finely reduced to a faint headache, and dizziness was down to a minimum. By the third day after the vaccine I was fine.
COVID19 vaccine vial was prepared on 11/06 at 12pm. Vaccine was administered on 11/08 at 1pm. Vial was kept in the refrigerator during this time frame.  Patient was informed and did not report any adverse events.
Initial report received on 28 September 2012 from the Investigator participating in a post-marketing study under the reference number M5A16. A case of pertussis disease in a 4-year-old male subject was identified by the investigator based on review of data from the Electronic Disease Surveillance System (EDSS) electronic database. The subject had received 4 doses of DAPTACEL: lot number C2933AB on 07 April 2008, lot number C2934BA on 11 June 2008, lot number C2934AA on 05 August 2008, and lot number C3082AA on 19 May 2009 (routes and sites of administration not reported). The subject developed a cough on 05 September 2012, approximately 3 years after the last dose. The subject also developed catarrhal illness, a paroxysmal cough with a whoop, apnea and sleep disturbance (onset dates not reported). Laboratory testing included positive PCR on 10 September 2012. Chest x-ray findings were negative for pneumonia. Corrective treatments consisted of azithromycin starting on 10 September 2012 for 5 days. The subject was not hospitalized. At the time of final contact on 19 September 2012, the subject's cough was still persisting. The duration of the cough was reported at that time as 14 days. Investigator causality assessment is not required as per protocol. Documents held by sender: None.
patient came in today presenting with a rash on her left arm (not at the injection site), it was a medium circular patch, along with 2 smaller ones. Patient stated rash was never at the injection site. she stated the rash started to appear 2 days after receiving her first covid dose (moderna). Patient stated since the rash started she has taken 4 benadryl, patient stated rash has also improved.
Physical aches; Just felt miserable; Extreme fatigue worse than COVID-19 just felt miserable; Higher fever 100.8; Some fatigue; Low grade fever 99.4; General ache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (General ache), PAIN (Physical aches), FEELING ABNORMAL (Just felt miserable), PYREXIA (Low grade fever 99.4) and FATIGUE (Extreme fatigue worse than COVID-19 just felt miserable) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 virus test positive (On 14Dec21 he tested positive for COVID 19.) on 14-Dec-2020.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced PAIN (General ache), PYREXIA (Low grade fever 99.4) and FATIGUE (Some fatigue). On 06-Feb-2021, the patient experienced PAIN (Physical aches), FEELING ABNORMAL (Just felt miserable), FATIGUE (Extreme fatigue worse than COVID-19 just felt miserable) and PYREXIA (Higher fever 100.8). On 07-Feb-2021, PAIN (General ache), PAIN (Physical aches), FEELING ABNORMAL (Just felt miserable), PYREXIA (Low grade fever 99.4), FATIGUE (Extreme fatigue worse than COVID-19 just felt miserable), PYREXIA (Higher fever 100.8) and FATIGUE (Some fatigue) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Feb-2020, Body temperature: 99.4 °F (High) Low grade fever. On 06-Feb-2021, Body temperature: 100.8 °F (High) High grade fever. On 14-Dec-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. Treatment medications were unknown.
Immediate redness and prurtitis at injection site.  About an hour later, throat itching and tightness and facial swelling. Responded to oral Benadryl.  Symptoms did not return
Headache, Myalgia, "First I was having muscle aches and jaw pain, along with night sweats which progressed to extreme fatigue and headaches. I am experiencing fatigue and flank pain, along with burning of my hands, ankles, and feet. With a continuation othe muscle pain and  Narrative: Employee self-treated at home stating: ""I used stuff like Tyenol & Ibuprofen, that's about it. Drinking stuff like tea to turn it around & amped up on my Vitamin C. "
minor allergic reaction; small hives on her thumb; skin was sensitive; This is a spontaneous report from a contactable consumer reported for herself. A 42-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date unknown) via unspecified route of administration at the right arm on 12Jan2021 15:15 at single dose for Covid-19 immunization in a hospital. Medical history included hyperthyroidism, allergies to medication, allergies to food. The patient was not diagnosed with COVID-19 prior to vaccination. The patient was not pregnant at the time of vaccination. Concomitant medications included unspecified medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 13Jan2021 07:30, the patient thought she was having a minor allergic reaction, she had some small hives on her thumb earlier and her skin was sensitive. The patient has not been tested for COVID-19 since the vaccination. The patient did not received treatment due to the events. The outcome of the events minor allergic reaction, small hives on her thumb, and skin was sensitive was recovering. The reporter considered the events non-serious which did not results in death, was not life threatening, did not cause/prolong hospitalization, was not disabling/incapacitating, and no congenital anomaly/birth defect.  Follow-up activities are possible, information on the batch number has been requested.
Within ten minutes of having the first vaccine, I developed a strong metallic taste in my mouth. This subsided within approximately 2 hours.  Seven days after having the first vaccine, I developed ?Covid arm? at the injection site. The area is red, swollen, and very itchy.
Pt. c/o tactile fever approx. 6-8hrs after Tdap vaccine given associated with "stiffness" in general with malaise. Taking ZPAK for pertussis exposure.
07/13/2021- in the morning, she developed a fever. She had a very average fever 101 to 102, and the next day her fever was 103.8 and hovering to 104. She had a fever for 5 whole days. She was fatigue and sore. She missed an entire week of camp and an entire week of soccer. I was giving her Tylenol and it would never bring her fever to normal. So I called her doctor on day 3, they told me they are seeing fever in their patients for up to a week and kind of keep an eye on her and have her rest and give her fluids. Note: She received her meningitis vaccine on 05/19/2021.
Started swelling at injection site, bumps/hives all over the skin, and puffy eyes. No difficulty breathing and no shortness of breath. Will take OTC Benadryl and follow up with PCP as needed or ER if has difficulty breathing
2nd day arm with fever, red swollen rash for shoulder to elbow;  2nd day extreme fatigue, lethargic, light headed, confusion, loss of appetite heart racing and then seemed to skip beats.  Saw doctor on March 3. symptoms continued 2 month, then began to lesson. To date only occasional heart palpatations. Some tiredness.
Fever for approximately 8 consecutive hours. Sweating, shivering, headache, sore throat, palpatations, and tachycardia. Fever ended, still have headache, sore throat.
This spontaneous report was received from a physician referring to a 12 year old female patient. On 05-APR-2016, the patient was intramuscularly vaccinated with the first dose of GARDASIL 9 (dose was not reported, lot # L048237 with 08-MAY-2017). On 05-APR-2016, 10 min after vaccination, the patient experienced swallowing difficulty, which patient described like swallowing blood. Upon examination patient was found to have an erythematous and edematous posterior pharyngeal area. The physician reported that the patient was treated with 25mg of BENADRYL and experienced a complete resolution of symptoms on the same day, within 30 minutes. Physician reported that vital signs were taken at the time of report and were within normal range. Causality assessment was not reported. Additional information has been requested.
This spontaneous report was received from a licensed practical nurse referring to a 27 year old patient of an unknown gender who on 19-MAR-2013, was vaccinated with a dose of MMR II (lot# 0259AE) 0.5 ml, subcutaneous in the left arm, which was improperly stored. MMR II was stored at 48 degrees F for total hours of 25.5. Per National Service Center - potency projection indicated administered doses of MMR II was expected to maintain a potency within label usage. This is one of several reports from the same reporter source. Additional information is not expected.
Intense headache; Shivering/chills; Horrible stomach ache / GI complants; Muscle cramps; Feeling horrible / Sick; I'm too weak; This case was reported by a consumer via call center representative and described the occurrence of headache in a 65-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of adverse reaction (received 1st dose on unknown date, refer case US2020AMR202885).   In October 2020, the patient received the 2nd dose of Shingrix. On an unknown date, 12 hrs after receiving Shingrix, the patient experienced headache, chills, stomach pain, muscle cramp, sickness and weakness. The patient was treated with paracetamol (Tylenol). On an unknown date, the outcome of the headache, chills, stomach pain, muscle cramp, sickness and weakness were not recovered/not resolved.   It was unknown if the reporter considered the headache, chills, stomach pain, muscle cramp, sickness and weakness to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix and 12 hours later began an intense headache, shivering, chills, horrible stomachache, and muscle cramps. The patient was sick and feeling horrible. The patient treated with Tylenol and reporter asked should couple that with aspiring.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR202885:same reporter
arm  was tender; sore; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (arm  was tender) and MYALGIA (sore) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041620A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TENDERNESS (arm  was tender) and MYALGIA (sore). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) at an unspecified dose and frequency and CORTISONE at an unspecified dose and frequency. At the time of the report, TENDERNESS (arm  was tender) outcome was unknown and MYALGIA (sore) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant medications information was reported.   This case was linked to MOD-2021-396212, MOD-2021-396344 (Patient Link).
Chills, fever, whole body ache (1st 24 hours), nausea, diarrhea (2nd & 3rd day)
Patient had trouble swallowing and tingling in the throat. Administered diphenhydramine and observed for 30 minutes. Symptoms resolved at that time and mother took patient home. after we recommended a follow-up with PCP
I tested positive for COVID-19 13 days after receiving my 4th dose of Moderna
Patient received PREVNAR 13 on 02/09/17, she reported soreness for a couple of days, 4 days later injection site showed signs of redness with erythema. She also stated she had started a fever.  She had seen her physician for another reason and he  indicated she was having and injection site reaction.
itchiness all over her body; rash all over arm; swelling; tiny bumps,bumps look like bug bites; redness; COVID arm; little pimples on my body; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SWELLING (swelling), MASS (tiny bumps,bumps look like bug bites), ERYTHEMA (redness), PAIN IN EXTREMITY (COVID arm) and ACNE (little pimples on my body) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, the patient experienced SWELLING (swelling), MASS (tiny bumps,bumps look like bug bites), ERYTHEMA (redness), PAIN IN EXTREMITY (COVID arm), ACNE (little pimples on my body) and RASH (rash all over arm). On 14-Apr-2021, the patient experienced PRURITUS (itchiness all over her body). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 1 dosage form. At the time of the report, SWELLING (swelling), MASS (tiny bumps,bumps look like bug bites), ERYTHEMA (redness), PAIN IN EXTREMITY (COVID arm) and RASH (rash all over arm) had not resolved and ACNE (little pimples on my body) and PRURITUS (itchiness all over her body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 02-May-2021: Updated patient details, product details. Added treatment medication. updated event details and event outcome. Added events pain in arm, pimples, rash.
Information has been received from a pharmacist concerning her 3 year old son with a history of Suspected Fifth disease (fever free) prior to vaccination (erythema infectiosum) and no drug reactions/allergies, who on 04-JAN-2008 was vaccinated SC in the left upper deltoid with a dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). There was no concomitant medication. On 05-JAN-2008, the patient's face was swollen and red with no other symptoms. On 06-JAN-2008, the rash reached a peak. By 08-JAN-2008, the rash was gone. On 08-JAN-2008 after the rash cleared, the patient developed a rash limited to the arms. The rash was described as raised, warm with clumps of rash on the back of the arms and forearms. The rash was "bad" for 2 days and got better without treatment by 11-JAN-2008 Since 11-JAN-2008 no rash had been present. On 14-JAN-2008, the patient was crying for no reason. No fever was present. On 15-JAN-2008, the patient woke up and felt fine. No other information was reported. There were no lab diagnostic studies performed. Unspecified medical attention was sought. There was no product quality complaint. Additional information has been requested.
Mother reported by phone next day after shot given stating that the baby developed fussiness, not sleeping well, runny nose and decrease in appetite. Appointment given for follow-up at 9am on 03/13/2002. They failed to come into the office so it was rescheduled for 03/14/2002.
Varicella vaccine given 8/2/17. Redness and hard lump at injection site on 8/14/17 that lasted 2-3 days. On 9/1/17, minimal coughing started. Early on 9/2/17, went to ER due to difficulty breathing and barking cough. A chest X-ray was taken and we were told it was viral pneumonia. There was no treatment given since you can't give antibiotics for viral pneumonia. Followed up with primary doctor on 9/5/17 and lungs sounded better. Since this episode, she has had reoccurring congestion and coughing through November 2017. We are not sure if that's related to the original episode.
On the 2nd, I noticed a sore on my abdomen. I put some ointment on it but it didn't get better. By the next night I noticed I had a rash that was spreading and I had pain that radiated around to my back. I realized it was shingles at that point.
Patient 66 y.o. male with a history of Protein S deficiency, PE, on chronic anticoagulation with warfarin, and previous DVT who presented to the Emergency Room with complaints of abdominal pain and groin pain for a week's duration. Associated with constipation and subjective fevers of 102F. He endorses nausea and vomiting. Last meal was yesterday. Drank water this afternoon. States he feels weak with a low appetite.  He was recently seen in the ER for similar right lower abdominal pain on 3/15 associated with "painful bowel movements and chills." At that time his CT was read as unremarkable. However, during this admission he underwent a CT scan which was significant for perianal abscess that has increased in size compared to CT obtained on 3/15. He was also found to be COVID positive. States he took warfarin yesterday and missed his dose today. Denies fecal incontinence. Denies a history of perianal abscess in the past.  In regards to his COVID infection patient denies known COVID positive contacts. He states he has had some shortness of breath but attributes this to his abdominal and perirectal pain.
Patient came to office for second dose of Pfizer vaccine and was given the bivalent booster dose instead of the original monovalent for her primary series. Father stated that patient is doing well and was advised to monitor for adverse reactions and to follow regular vaccination schedule.
Patient started to itch 5 minutes after receiving booster dose. Patient complained of tingling  in her head.
shoulder pain both side, but most prominent in the left side; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (shoulder pain both side, but most prominent in the left side) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     Concomitant products included ATORVASTATIN, CAFFEINE, CALCIUM CITRATE, CALCIUM GLUCONATE, VITAMINS NOS (BIOPLUS) and Hypochloride for an unknown indication.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (shoulder pain both side, but most prominent in the left side). At the time of the report, ARTHRALGIA (shoulder pain both side, but most prominent in the left side) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details are not provided by reporter.   Reporter did not allow further contact
fever; This case was reported by a other health professional via interactive digital media and described the occurrence of fever in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced fever. On an unknown date, the outcome of the fever was unknown.   It was unknown if the reporter considered the fever to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The reporter asked can 2nd dose of vaccine cause fever.